Icodextrin Dialysate Improves Nutritional and Inflammatory Profiles in Peritoneal Dialysis Patients

REFERENCES

• Wiggins KJ, Rumpsfeld M, Blizzard S, Johnson DW. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure. Nephrology (Carlton). Feb, 2005; 10(1)33–36
   Google Scholar
• Wolfson M, Ogrinc F, Mujais S. Review of clinical trial experience with icodextrin. Kidney Int Suppl. Oct, 2002, 81: S46–S52
   Google Scholar
• Amici G, Da Rin G, Agostini A, Velo S, Bocci C. Ten years after MIDAS: Icodextrin lights and shadows. Contrib Nephrol. 2003, 140: 76–81
   Google Scholar
• Gursu EM, Ozdemir A, Yalinbas B, et al. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients. Clin Nephrol. Oct, 2006; 66(4)263–268
   Google Scholar
• Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. Jul, 2001; 12(7)1549–1557
   PubMedGoogle Scholar
• Wu MS, Lin CL, Chang CT, Wu CH, Huang JY, Yang CW. Improvement in clinical outcome by early nephrology referral in type II diabetics on maintenance peritoneal dialysis. Perit Dial Int. Jan–Feb, 2003; 23(1)39–45
   PubMed Web of Science ®Google Scholar
• Wang T, Heimburger O, Bergstrom J, Lindholm B. Nutritional problems in peritoneal dialysis: An overview. Perit Dial Int. 1999; 19(Suppl. 2)S297–S303
   PubMedGoogle Scholar
• Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Peritoneal Dialysis Bulletin. 1987; 7(3)138–147
   Web of Science ®Google Scholar
• Katzarski K, Charra B, Laurent G, et al. Multifrequency bioimpedance in assessment of dry weight in hemodialysis. Nephrol Dial Transplant. 1996; 11((Suppl.) 2)20–23
   Google Scholar
• Kopple JD, Jones MR, Keshaviah PR, et al. A proposed glossary for dialysis kinetics. Am J Kidney Dis. 1995; 26(6)963–981
   Google Scholar
• Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005; 45(5)891–902
   PubMed Web of Science ®Google Scholar
• Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters. Nephrol Dial Transplant. Jun, 1998; 13(6)1476–1483
   Google Scholar
• Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet. 1999; 353(9167)1838–1842
   PubMed Web of Science ®Google Scholar
• Mitch WE. Malnutrition: A frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002; 110(4)437–439
   Google Scholar
• Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996; 335(25)1897–1905
   PubMedGoogle Scholar
• Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int. 2003; 23(2)174–183
   Google Scholar
• Selim G, Stojceva-Taneva O, Zafirovska K, et al. Inflammation predicts all-cause and cardiovascular mortality in hemodialysis patients. Prilozi. 2006; 27(1)133–144
   Google Scholar
• Stenvinkel P. Leptin and its clinical implications in chronic renal failure. Miner Electrolyte Metab. 1999; 25(4–6)298–302
   Google Scholar
• Rahmouni K, Haynes WG. Leptin and the cardiovascular system. Recent Prog Horm Res. 2004; 59: 225–244
   PubMedGoogle Scholar
• Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol. 1998; 9(6)1080–1084
   Google Scholar
• Vignioble M, Brichard S, Jadoul M, Goffin E. Serum leptin concentration in peritoneal dialysis patients: Determinants, longitudinal evolution and circadian rhythm. Acta Clin Belg. 2001; 56(3)173–179
   Web of Science ®Google Scholar
• Opatrna S, Racek J, Stehlik P, et al. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis.]. Cas Lek Cesk. 2002; 141(9)281–285
   PubMedGoogle Scholar
• Wu CH, Huang CC, Huang JY, Wu MS, Leu ML. High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial. 1996; 12: 105–109
   Google Scholar
• Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int. 2000; 20(Suppl. 2)S106–S113
   Google Scholar
• Wolfson M, Piraino B, Hamburger RJ, Morton AR. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis. Nov, 2002; 40(5)1055–1065
   Google Scholar
• Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol. Feb, 2005; 16(2)546–554
   PubMedGoogle Scholar
• Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol. Sep, 2003; 14(9)2338–2344
   Google Scholar
• Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant. Jun, 2000; 15(6)862–866
   Google Scholar
• Davies SJ. Exploring new evidence of the clinical benefits of icodextrin solutions. Nephrol Dial Transplant. Jul, 2006; 21(Suppl. 2)ii47–ii50
   Google Scholar
• le Poole CY, Welten AG, Weijmer MC, Valentijn RM, van Ittersum FJ, ter Wee PM. Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit Dial Int. Feb, 2005; 25(Suppl. 3)S64–S68
   Google Scholar
• Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney International. Apr, 2003; 63(4)1556–1563
   PubMedGoogle Scholar
• Dumler F. Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. Asaio J. May–Jun, 2003; 49(3)282–286
   Google Scholar
• Wang AY, Sanderson J, Sea MM, Wang M, Lam CW, Li PK, et al. Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. The American Journal of Clinical Nutrition. Apr, 2003; 77(4)834–841
   PubMedGoogle Scholar
• Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients?. Am J Kidney Dis. Apr, 2002; 39(4)872–875
   PubMed Web of Science ®Google Scholar
• Freeman LM, Roubenoff R. The nutrition implications of cardiac cachexia. Nutrition Reviews. Oct, 1994; 52(10)340–347
   Google Scholar
• Fantino M, Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiology & Behavior. Mar, 1993; 53(3)477–483
   Google Scholar
• Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. The Journal of Clinical Investigation. Dec 1, 1997; 100(11)2777–2782
   PubMedGoogle Scholar